Literature DB >> 8879857

Risk modeling in acute renal failure requiring dialysis: the introduction of a new model.

E P Paganini1, W K Halstenberg, M Goormastic.   

Abstract

Predicting patient outcome in acute renal failure has become increasingly important as technology advances and ethical questions arise concerning life supporting therapies. We propose a new model which uses mortality as an endpoint and may be applied to the acute renal failure patient in the ICU setting who requires dialysis. This model is based on our ICU acute renal failure registry and has been prospectively validated for our institution. Our registry for the purposes of developing this model consists of data from 512 ICU patients requiring acute dialysis from 1988 until 1992. The model was developed by testing a variety of potential risk factors for mortality in a univariate analysis (Student's t-test and Chi square), and those factors found to be significant (p < 0.05) were subsequently tested in a multivariate fashion. The factors found significant included male gender, respiratory failure requiring intubation, hematologic dysfunction (platelet count < 50,000, leukocyte count < 2,500, or bleeding diathesis), bilirubin < 2.0 mg/dl, the absence of surgery, serum creatinine on the first dialysis treatment day, an increasing number of failed organ systems, and an increased BUN from the time of admission. Weights are assigned to each variable based on the odds ratio, and a score is generated with a range of 0 to 20. The initial data for the registry demonstrates good fit using the Hosmer and Lemeshow goodness-of-fit table. The model is next validated in 88 patients from 1993 through February 1994, then prospectively tested in 35 additional patients using a standard data collection form, and the model continues to demonstrate good fit. Although this model has been prospectively validated at our institution, this model or any such predictive model should be used with caution if not independently validated at any institution which proposes its use.

Entities:  

Mesh:

Year:  1996        PMID: 8879857

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  23 in total

1.  Pharmacokinetics and pharmacodynamics of piperacillin-tazobactam in 42 patients treated with concomitant CRRT.

Authors:  Seth R Bauer; Charbel Salem; Michael J Connor; Joseph Groszek; Maria E Taylor; Peilin Wei; Ashita J Tolwani; William H Fissell
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 8.237

2.  Dialysis versus nondialysis in patients with AKI: a propensity-matched cohort study.

Authors:  F Perry Wilson; Wei Yang; Carlos A Machado; Laura H Mariani; Yuliya Borovskiy; Jeffrey S Berns; Harold I Feldman
Journal:  Clin J Am Soc Nephrol       Date:  2014-03-20       Impact factor: 8.237

3.  Biomarker Enhanced Risk Prediction for Adverse Outcomes in Critically Ill Patients Receiving RRT.

Authors:  Francis Pike; Raghavan Murugan; Christopher Keener; Paul M Palevsky; Anitha Vijayan; Mark Unruh; Kevin Finkel; Xiaoyan Wen; John A Kellum
Journal:  Clin J Am Soc Nephrol       Date:  2015-06-05       Impact factor: 8.237

4.  Estrogen protects renal endothelial barrier function from ischemia-reperfusion in vitro and in vivo.

Authors:  Michael P Hutchens; Tetsuhiro Fujiyoshi; Radko Komers; Paco S Herson; Sharon Anderson
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-23

Review 5.  Mechanisms and mediators of lung injury after acute kidney injury.

Authors:  Sarah Faubel; Charles L Edelstein
Journal:  Nat Rev Nephrol       Date:  2015-10-06       Impact factor: 28.314

6.  Plasma inflammatory and apoptosis markers are associated with dialysis dependence and death among critically ill patients receiving renal replacement therapy.

Authors:  Raghavan Murugan; Xiaoyan Wen; Nilesh Shah; Minjae Lee; Lan Kong; Francis Pike; Christopher Keener; Mark Unruh; Kevin Finkel; Anitha Vijayan; Paul M Palevsky; Emil Paganini; Melinda Carter; Michele Elder; John A Kellum
Journal:  Nephrol Dial Transplant       Date:  2014-03-11       Impact factor: 5.992

7.  Associations between Intensity of RRT, Inflammatory Mediators, and Outcomes.

Authors:  Raghavan Murugan; Xiaoyan Wen; Christopher Keener; Francis Pike; Paul M Palevsky; Mark Unruh; Kevin Finkel; Anitha Vijayan; Michele Elder; Yi-Fan Chen; John A Kellum
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-10       Impact factor: 8.237

8.  Predictors of death and dialysis in severe AKI: the UPHS-AKI cohort.

Authors:  Francis Perry Wilson; Wei Yang; Harold I Feldman
Journal:  Clin J Am Soc Nephrol       Date:  2012-12-20       Impact factor: 8.237

9.  Correlation between parameters at initiation of renal replacement therapy and outcome in patients with acute kidney injury.

Authors:  Marlies Ostermann; René Ws Chang
Journal:  Crit Care       Date:  2009-11-04       Impact factor: 9.097

10.  Protective role of testosterone in ischemia-reperfusion-induced acute kidney injury.

Authors:  Andrea Soljancic; Arnaldo Lopez Ruiz; Kiran Chandrashekar; Rodrigo Maranon; Ruisheng Liu; Jane F Reckelhoff; Luis A Juncos
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-04-03       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.